Good spotting, nice speculationI wonder how bisantrene (or other FTO inhibitor) would compare to B2 adrenoceptor agonists (like Atrogi's drug) when it comes to T2D therapies. I remember there being plenty of speculation around wanting to explore the use of bisantrene in the management of T2D and dementia a few years back... Maybe we'll get to see something...?
Good spotting, nice speculation ;) I wonder how bisantrene (or...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.015(1.22%) |
Mkt cap ! $215.4M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.23 | $106.2K | 85.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 11900 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 819 | 1 |
View Market Depth
| Last trade - 15.56pm 26/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |